ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) today announced that it intends to commence an underwritten public offering of $75,000,000 of shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE